PDF下载 ( 212 KB)
Research advances in T helper 17 cells in chronic inflammatory liver diseases
-
摘要:
辅助性T淋巴细胞17（Th17）由初始CD4+T淋巴细胞分化而来,可分泌IL-17、IL-21、IL-22等一系列细胞因子,同时接受许多细胞因子和基因的调节,在各种炎性疾病中发挥重要作用。Th17分布广泛,与多种系统疾病均有联系,可通过分泌促炎因子、拮抗调节性T淋巴细胞的免疫抑制作用,参与慢性炎性/自身免疫性疾病的调控。归纳和概述了近几年Th17与各种慢性炎症性肝病发病机制的相关研究,为其科研思路和临床治疗提供一定的参考。
Abstract:T helper 17( Th17) cells,differentiated from nave CD4 + T cells,can secrete a series of cytokines including interleukin-17,interleukin-21,and interleukin-22 and are meanwhile regulated by a variety of cytokines and genes,playing an important role in various inflammatory diseases. Th17 cells are widely distributed in vivo and are associated with diseases in many systems. They are involved in the regulation of chronic inflammatory/autoimmune diseases by secreting pro-inflammatory factors and antagonizing the immunosuppressive effect of regulatory T cells. This article reviews the recent studies on the association between Th17 cells and the pathogenesis of various chronic inflammatory liver diseases,so as to provide a reference for scientific research and clinical treatment.
-
Key words:
- hepatitis,chronic /
- Th17 cells /
- cytokines
-
[1] LEE GR. The balance of Th17 versus Treg cells in autoimmunity[J]. Int J Mol Sci,2018,19(3):730. [2] HARRINGTON LE,HATTON RD,MANGAN PR,et al. Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol,2005,6(11):1123-1132. [3] PARK H,LI Z,YANG XO,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J]. Nat Immunol,2005,6(11):1133-1141. [4] BERINGER A,MIOSSEC P. IL-17 and IL-17-producing cells and liver diseases,with focus on autoimmune liver diseases[J]. Autoimmun Rev,2018,17(12):1176-1185. [5] BROCKMANN L,GIANNOU AD,GAGLIANI N,et al. Regulation of T(H)17 cells and associated cytokines in wound healing,tissue regeneration,and carcinogenesis[J]. Int J Mol Sci,2017,18(5):16. [6] DUDAKOV JA,HANASH AM,VAN DEN BRINK MRM. Interleukin-22:Immunobiology and pathology[M]//LITTMAN DR,YOKOYAMA WM. Annual Review of Immunology Vol 33.Palo Alto; Annual Reviews. 2015:747-785. [7] EYERICH K,DIMARTINO V,CAVANI A. IL-17 and IL-22 in immunity:Driving protection and pathology[J]. Eur J Immunol,2017,47(4):607-614. [8] BAO S,ZHAO Q,ZHENG J,et al. Interleukin-23 mediates the pathogenesis of LPS/Gal N-induced liver injury in mice[J]. Int Immunopharmacol,2017,46:97-104. [9] WEI CB,TAO K,JIANG R,et al. Quercetin protects mouse liver against triptolide-induced hepatic injury by restoring Th17/Treg balance through Tim-3 and TLR4-MyD88-NF-κB pathway[J]. Int Immunopharmacol,2017,53:73-82. [10] WAN Z,ZHOU Z,LIU Y,et al. Regulatory T cells and T helper 17 cells in viral infection[J]. Scand J Immunol,2020,91(5):e12873. [11] PAQUISSI FC. Immunity and fibrogenesis:The role of Th17/IL-17 axis in HBV and HCV-induced chronic hepatitis and progression to cirrhosis[J]. Front Immunol,2017,8:1195. [12] LI X,SU Y,HUA X,et al. Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis[J]. J Transl Med,2017,15(1):75. [13] LI K,LIU H,GUO T. Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients[J]. Clin Res Hepatol Gastroenterol,2017,41(4):399-407. [14] HU Z,LUO D,WANG D,et al. IL-17 activates the IL-6/STAT3 signal pathway in the proliferation of hepatitis B virusrelated hepatocellular carcinoma[J]. Cell Physiol Biochem,2017,43(6):2379-2390. [15] TIAN CH,DAI J,ZHANG W,et al. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection[J]. Medicine(Baltimore),2019,98(23):e15924. [16] CACHEM F,DIAS AS,MONTEIRO C,et al. The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C[J]. Immunology,2017,151(2):167-176. [17] NYIRENDA MH,SANVITO L,DARLINGTON PJ,et al. TLR2stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function[J]. J Immunol,2011,187(5):2278-2290. [18] LIU X,GUAN JH,JIANG BC,et al. Toll-like receptor 2 modulates the balance of regulatory T cells and T helper 17 cells in chronic hepatitis C[J]. Viral Immunol,2016,29(6):322-331. [19] QIN L,ZHOU YC,WU HJ,et al. Notch signaling modulates the balance of regulatory T cells and T helper 17 cells in patients with chronic hepatitis C[J]. DNA Cell Biol,2017,36(4):311-320. [20] HE B,WU L,XIE W,et al. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice[J]. BMC Immunol,2017,18(1):33. [21] HAUSE RJ,PRITCHARD CC,SHENDURE J,et al. Corrigendum:Classification and characterization of microsatellite instability across 18 cancer types[J]. Nat Med,2017,23(10):1241. [22] LIU Y,YAN W,YUAN W,et al. Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis[J]. Clin Immunol,2019,198:79-88. [23] XIA G,WU S,WANG X,et al. Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation[J]. Can J Physiol Pharmacol,2018,96(12):1293-1300. [24] HU ED,CHEN DZ,WU JL,et al. High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier[J]. Cell Immunol,2018,328:24-32. [25] CICHOZ·-LACH H,GRYWALSKA E,MICHALAK A,et al. Deviations in peripheral blood cell populations are associated with the stage of primary biliary cholangitis and presence of itching[J].Arch Immunol Ther Exp(Warsz),2018,66(6):443-452. [26] SUN Q,WANG Q,FENG N,et al. The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis[J]. Ann Transl Med,2019,7(16):389. [27] SONG Y,YANG H,JIANG K,et al. miR-181a regulates Th17cells distribution via up-regulated BCL-2 in primary biliary cholangitis[J]. Int Immunopharmacol,2018,64:386-393. -
本文二维码
计量
- 文章访问数: 681
- HTML全文浏览量: 58
- PDF下载量: 73
- 被引次数: 0
下载:
